Foresite Capital Management Vi LLC Viridian Therapeutics, Inc.\De Transaction History
Foresite Capital Management Vi LLC
- $183 Billion
- Q1 2025
A detailed history of Foresite Capital Management Vi LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 1,974 shares of VRDN stock, worth $29,234. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,974
Previous 1,974
-0.0%
Holding current value
$29,234
Previous $37.8 Million
29.68%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding VRDN
# of Institutions
189Shares Held
79.6MCall Options Held
92.2KPut Options Held
55.2K-
Deep Track Capital, LP Greenwich, CT5.38MShares$79.7 Million2.54% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$70.7 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.7MShares$69.6 Million5.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.56MShares$67.6 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$57.5 Million12.64% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $591M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...